Delivery Order SPE2DB20D9331-SPE2DB25FL1P4
Award Date 7/17/25
Potential Completion Date 8/7/25
Potential Value $148K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 milliliter vials. This firm fixed-price delivery order is expected to reach completion by August 29, 2025, and represents a continuation of the companies' ongoing pharmaceutical supply relationship. The award carries no set-aside designation, indicating that DMS...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas (5 ml vials). The contract is firm fixed-price with an ultimate completion date of September 23, 2025, and was awarded on September 2, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $148,084.30 for 3,750 units of Asparlas (5 milliliter vials). The contract, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas 5 mL vials. The contract, valued at $59,233.74, is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. This award was issued without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $148,084.30 by the Defense Logistics Agency on September 26, 2025, for the supply of 3,750 units of Asparlas (5 milliliter vials). The award carries a firm fixed-price structure with an ultimate completion date of October 20, 2025, and represents no set-aside designation. The place of performance is located in Park Ridge, Illinois, where...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, with a ceiling value of $29,616.86 for the supply of 3,750 units of Asparlas 5 ML vials. Asparlas is a leukemia treatment medication, and this delivery order will be fulfilled from DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,614.78 fixed-price contract is for the delivery of 3,750 units of the drug Asparlas (5 mL vials) with a performance period through May 13, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the agency to...
- On August 21, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $59,233.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order calls for 3,750 units of Asparlas (5 mL vials) to be delivered by September 12, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. Asparlas is a pediatric acute lymphoblastic...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $59,233.74 by the Defense Logistics Agency on September 10, 2025. The delivery order, with an ultimate completion date of October 1, 2025, calls for the supply of 3,750 units of Asparlas in 5 milliliter vials. This award was issued without a set-aside designation and represents a specific product delivery under DMS...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $52,599.60, is for the delivery of 3,750 units of the pharmaceutical product Asparlas (5 ml vial) by September 14, 2023. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...